Kyowa Kirin Pharmaceutical Development, Inc.

212 Carnegie Ctr Ste 101, Princeton, New Jersey, United States

Clinical Trials

13 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

81.3%

Phase 3

18.8%

Trial Status Distribution

Active, not recruiting

81.3%

Completed

18.8%

Clinical Trials

Trials sponsored by this organization (16)

A Phase 3, Long-term, Open-label Study of Istradefylline inSubjects with Moderate to Severe Parkinson’s Disease

Phase 1

Active, not recruiting

Feb 2016300 participants

A Phase 3, Long-term, Open-label Study of Istradefylline inSubjects with Moderate to Severe Parkinson’s Disease

Phase 1

Active, not recruiting

Dec 2015300 participants

A Phase 3, Long-term, Open-label Study of Istradefylline inSubjects with Moderate to Severe Parkinson’s Disease

Phase 1

Active, not recruiting

Dec 2015300 participants

A clinical study to test the safety and possible benefits of an investigational study drug, KHK4083, in patients with ulcerative colitis.

Phase 1

Active, not recruiting

Dec 201560 participants

A clinical study to test the safety and possible benefits of an investigational study drug, KHK4083, in patients with ulcerative colitis.

Phase 1

Active, not recruiting

Dec 201560 participants

A clinical study to test the safety and possible benefits of an investigational study drug, KHK4083, in patients with ulcerative colitis.

Phase 1

Active, not recruiting

Nov 201560 participants

Study of KW-0761 Versus Vorinostat In Relapsed/Refractory CTCL.

Phase 3

Completed

interventional

Jul 2014372 participants

Study to test the safety and effect of an investigational study drug, Istradefylline, in moderate to severe Parkinson's Disease (PD) patients who have been treated with levodopa combination therapy.

Phase 1

Active, not recruiting

Feb 2014609 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations